Table of contents
- Trade marks/passing off
- Court upholds Viagra’s opposition to STYRIAGRA trade mark (Gall Pharma GmbH v EUIPO)
- EU trade mark MASSI—res judicata and invalidity (J-M.-E.V. e hijos v EUIPO)
- AG opines on trade mark case concerning entitlement to file notice of opposition (QuaMa v EUIPO)
- Copyright and associated rights
- Consultation launched on UK implementation of Marrakesh Treaty
- Brexit
- Government responds to report on UK-EU science and innovation collaboration post-Brexit
- Reputation Management
- Court strikes our defence pleadings in libel claim (Miah v British Broadcasting Corporation)
More sections of this document available when you sign-in to Lexis+ or register for a free trial.
Article summary
This week’s edition of IP weekly highlights includes news analyses on a number of trade marks cases, including the case of Gall Pharma GmbH v EUIPO which concerned an application for the trademark ‘STYRIAGRA’, details of a consultation seeking views on the implementation of the Marrakesh Treaty in the UK, and an update on the government’s response to the House of Commons Science and Technology Select Committee report ‘Brexit, sciences and innovation’.
To continue reading this news article, as well as thousands of others like it, sign in with LexisNexis or register for a free trial